Athira Pharma (ATHA) Short Interest Ratio & Short Volume $0.40 0.00 (-1.13%) Closing price 04:00 PM EasternExtended Trading$0.39 0.00 (-0.88%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Athira Pharma Short Interest DataAthira Pharma (ATHA) has a short interest of 945,300 shares, representing 2.80% of the float (the number of shares available for trading by the public). This marks a -8.22% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 115,008 shares to cover all short positions.Current Short Interest945,300 sharesPrevious Short Interest1,030,000 sharesChange Vs. Previous Month-8.22%Dollar Volume Sold Short$359.21 thousandShort Interest Ratio1.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares39,440,000 sharesFloat Size33,820,000 sharesShort Percent of Float2.80%Today's Trading Volume110,580 sharesAverage Trading Volume115,008 sharesToday's Volume Vs. Average96% Short Selling Athira Pharma? Sign up to receive the latest short interest report for Athira Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATHA Short Interest Over TimeATHA Days to Cover Over TimeATHA Percentage of Float Shorted Over Time Athira Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025945,300 shares $359.21 thousand -8.2%2.8%1.7 $0.38 7/15/20251,030,000 shares $408.19 thousand -22.0%3.1%1.8 $0.40 6/30/20251,320,000 shares $398.64 thousand -10.8%3.9%2.3 $0.30 6/15/20251,480,000 shares $449.92 thousand +65.4%4.4%2.7 $0.30 5/31/2025894,900 shares $269.99 thousand +19.4%2.7%1.6 $0.30 5/15/2025749,800 shares $209.27 thousand -12.3%2.2%3.6 $0.28 4/30/2025855,100 shares $240.80 thousand +3.5%2.5%4.3 $0.28 4/15/2025826,600 shares $195.90 thousand -11.6%2.5%3.8 $0.24 3/31/2025934,500 shares $261.66 thousand -10.1%2.6%4.6 $0.28 3/15/20251,040,000 shares $348.71 thousand +17.3%2.9%4.6 $0.34 Get the Latest News and Ratings for ATHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025886,300 shares $364.00 thousand -0.2%2.5%3.7 $0.41 2/15/2025888,000 shares $415.58 thousand -6.5%2.5%3.4 $0.47 1/31/2025949,500 shares $498.77 thousand -30.7%2.7%2.1 $0.53 1/15/20251,370,000 shares $742.40 thousand +17.1%3.9%0.3 $0.54 12/31/20241,170,000 shares $686.44 thousand -17.6%3.3%0.3 $0.59 12/15/20241,420,000 shares $830.56 thousand -21.6%4.0%0.3 $0.58 11/30/20241,810,000 shares $1.19 million -18.5%5.1%0.4 $0.66 11/15/20242,220,000 shares $1.49 million +43.2%6.2%0.4 $0.67 10/31/20241,550,000 shares $663.56 thousand -0.6%4.4%0.3 $0.43 10/15/20241,560,000 shares $693.26 thousand -0.6%4.4%1.9 $0.44 9/30/20241,570,000 shares $700.22 thousand -4.9%4.4%2.1 $0.45 9/15/20241,650,000 shares $871.37 thousand +66.2%4.7%2.3 $0.53 8/31/2024992,900 shares $3.07 million +0.2%2.8%1.7 $3.09 8/15/2024990,700 shares $2.96 million +0.2%2.8%7.4 $2.99 7/31/2024989,200 shares $3.16 million -8.4%2.8%7.6 $3.19 7/15/20241,080,000 shares $3.63 million -1.8%3.1%7.5 $3.36 6/30/20241,100,000 shares $2.92 million +8.9%3.1%7 $2.65 6/15/20241,010,000 shares $2.57 million +13.6%2.9%5.8 $2.54 5/31/2024889,500 shares $2.33 million -3.7%2.5%3.4 $2.62 5/15/2024923,300 shares $2.04 million -12.1%2.6%3 $2.21 4/30/20241,050,000 shares $2.07 million +1.0%3.0%3.1 $1.97 4/15/20241,040,000 shares $2.14 million +3.0%2.9%2.9 $2.06 3/31/20241,010,000 shares $2.77 million +3.1%2.9%2.5 $2.74 3/15/2024979,300 shares $2.57 million +25.0%2.8%2.2 $2.62 2/29/2024783,600 shares $3.02 million +20.5%2.2%2 $3.85 2/15/2024650,300 shares $2.38 million -9.4%1.8%1.9 $3.66 1/31/2024717,600 shares $2.27 million +39.6%2.1%2.2 $3.17 1/15/2024513,900 shares $1.54 million +25.4%1.5%1.6 $3.00 12/31/2023409,900 shares $996.06 thousand -16.6%1.2%1.4 $2.43 12/15/2023491,600 shares $1.14 million -1.6%1.4%2.3 $2.31Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad)For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.Click here to get your free advisor matches and start planning your legacy today. 11/30/2023499,600 shares $719.42 thousand +3.0%1.4%2.7 $1.44 11/15/2023484,900 shares $770.99 thousand -8.8%1.4%2.9 $1.59 10/31/2023531,500 shares $829.14 thousand -6.2%1.5%3.6 $1.56 10/15/2023566,700 shares $1.01 million -23.6%1.6%4 $1.79 9/30/2023741,900 shares $1.50 million -7.6%2.1%5.1 $2.02 9/15/2023803,300 shares $1.62 million -2.5%2.3%5.3 $2.02 8/31/2023823,500 shares $1.84 million -17.3%2.3%3.4 $2.23 8/15/2023996,000 shares $2.66 million -16.3%2.8%3.8 $2.67 7/31/20231,190,000 shares $3.47 million -3.3%3.4%4.7 $2.92 7/15/20231,230,000 shares $3.78 million +7.0%3.5%4.9 $3.07 6/30/20231,150,000 shares $3.39 million -46.0%3.3%4.4 $2.95 6/15/20232,130,000 shares $6.48 million +3.9%6.1%7.7 $3.04 5/31/20232,050,000 shares $5.68 million No Change5.8%9 $2.77 5/15/20232,050,000 shares $5.88 million -5.5%5.8%9.6 $2.87 4/30/20232,170,000 shares $6.05 million -1.8%6.4%9.6 $2.79 4/15/20232,210,000 shares $5.68 million -9.4%6.5%8.3 $2.57 3/31/20232,440,000 shares $6.10 million +8.4%6.8%7.7 $2.50 3/15/20232,250,000 shares $6.05 million +9.8%N/A6.9 $2.69 2/28/20232,050,000 shares $6.31 million +5.7%5.5%6.3 $3.08 2/15/20231,940,000 shares $6.44 million +4.9%5.2%5.9 $3.32 1/31/20231,850,000 shares $7.47 million +20.9%5.0%5.6 $4.04 1/15/20231,530,000 shares $5.89 million No Change4.1%4.8 $3.85 12/30/20221,530,000 shares $4.85 million -1.9%4.1%5.5 $3.17 12/15/20221,560,000 shares $4.96 million -4.3%N/A5.9 $3.18 11/30/20221,630,000 shares $5.07 million -3.0%N/A6.4 $3.11 11/15/20221,680,000 shares $5.29 million -6.2%N/A6.9 $3.15 10/31/20221,790,000 shares $5.92 million -2.2%N/A7 $3.31 10/15/20221,830,000 shares $5.87 million +0.6%5.1%5.9 $3.21 9/30/20221,820,000 shares $5.41 million -2.2%5.1%5.6 $2.97 9/15/20221,860,000 shares $6.64 million +3.3%5.2%3.3 $3.57 8/31/20221,800,000 shares $6.08 million -1.1%5.0%1.9 $3.38 8/15/20221,820,000 shares $7.10 million +2.8%5.1%1.9 $3.90 7/31/20221,770,000 shares $6.16 million -12.8%5.1%1.8 $3.48 7/15/20222,030,000 shares $6.98 million -27.2%5.9%2.2 $3.44 6/30/20222,790,000 shares $8.51 million -11.2%8.0%3.1 $3.05 6/15/20223,140,000 shares $25.81 million +6.8%9.0%4.1 $8.22 5/31/20222,940,000 shares $26.70 million +1.4%8.5%10.1 $9.08 5/15/20222,900,000 shares $24.01 million +7.4%8.3%10 $8.28 4/30/20222,700,000 shares $27.78 million +20.0%7.8%9.7 $10.29 4/15/20222,250,000 shares $26.46 million -1.3%6.5%7.8 $11.76 3/31/20222,280,000 shares $30.78 million -17.1%6.6%7.7 $13.50 3/15/20222,750,000 shares $26.57 million +13.2%8.0%10.3 $9.66 2/28/20222,430,000 shares $22.26 million +3.0%7.0%8.4 $9.16 2/15/20222,360,000 shares $24.00 million +18.6%6.8%7.5 $10.17 1/31/20221,990,000 shares $20.50 million -2.9%6.3%5.5 $10.30 1/15/20222,050,000 shares $22.65 million +0.5%6.0%5 $11.05 12/31/20212,040,000 shares $26.58 million +15.3%6.0%4.6 $13.03 12/15/20211,770,000 shares $22.97 million -9.2%5.2%4.1 $12.98 11/30/20211,950,000 shares $26.29 million +28.3%5.7%4.4 $13.48 11/15/20211,520,000 shares $23.85 million +29.9%4.4%3.6 $15.69Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged. 10/29/20211,170,000 shares $15.29 million +9.4%3.4%2.9 $13.07 10/15/20211,070,000 shares $10.23 million -6.1%3.2%2.9 $9.56 9/30/20211,140,000 shares $10.69 million -15.6%3.4%2.8 $9.38 9/15/20211,350,000 shares $13.62 million +20.5%4.0%2.4 $10.09 8/31/20211,120,000 shares $11.86 million -9.7%3.3%0.9 $10.59 8/13/20211,240,000 shares $12.19 million -6.1%3.6%1 $9.83 7/30/20211,320,000 shares $12.69 million No Change4.0%1.1 $9.61 7/15/20211,320,000 shares $13.09 million +9.1%4.0%1.1 $9.92 6/30/20211,210,000 shares $12.39 million -28.4%3.6%1.1 $10.24 6/15/20211,690,000 shares $31.65 million +21.6%5.1%1.7 $18.73 5/28/20211,390,000 shares $27.72 million +53.8%4.2%4.6 $19.94 5/14/2021904,000 shares $16.34 million +7.1%2.7%3.3 $18.08 4/30/2021843,800 shares $16.22 million -27.9%2.5%2.8 $19.22 4/15/20211,170,000 shares $20.46 million +25.6%3.5%3.1 $17.49 3/31/2021931,400 shares $15.74 million +16.3%2.8%2.3 $16.90 3/15/2021800,900 shares $17.27 million +26.4%2.5%1.8 $21.56 2/26/2021633,800 shares $13.24 million -4.4%2.0%1.5 $20.89 2/12/2021663,100 shares $14.87 million -17.9%2.0%1.7 $22.42 1/29/2021807,900 shares $17.14 million -13.8%2.5%2.2 $21.21 1/15/2021937,200 shares $25.11 million No Change3.0%2.7 $26.79 ATHA Short Interest - Frequently Asked Questions What is Athira Pharma's current short interest? Short interest is the volume of Athira Pharma shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 945,300 shares of ATHA short. 2.80% of Athira Pharma's shares are currently sold short. Learn More on Athira Pharma's current short interest. What is a good short interest ratio for Athira Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATHA shares currently have a short interest ratio of 2.0. Learn More on Athira Pharma's short interest ratio. What is a good short interest percentage for Athira Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.80% of Athira Pharma's floating shares are currently sold short. Is Athira Pharma's short interest increasing or decreasing? Athira Pharma saw a decrease in short interest in July. As of July 31st, there was short interest totaling 945,300 shares, a decrease of 8.2% from the previous total of 1,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Athira Pharma's float size? Athira Pharma currently has issued a total of 39,440,000 shares. Some of Athira Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Athira Pharma currently has a public float of 33,820,000 shares. How does Athira Pharma's short interest compare to its competitors? 2.80% of Athira Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Athira Pharma: Aligos Therapeutics, Inc. (8.51%), ALX Oncology Holdings Inc. (12.18%), Invivyd, Inc. (4.37%), Adverum Biotechnologies, Inc. (7.13%), Adlai Nortye Ltd. Sponsored ADR (0.01%), InflaRx N.V. (1.68%), Werewolf Therapeutics, Inc. (2.47%), DURECT Corporation (1.45%), Precision BioSciences, Inc. (14.75%), ImageneBio, Inc. (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Athira Pharma stock? Short selling ATHA is an investing strategy that aims to generate trading profit from Athira Pharma as its price is falling. ATHA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Athira Pharma? A short squeeze for Athira Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHA, which in turn drives the price of the stock up even further. How often is Athira Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Aligos Therapeutics Short Interest Data ALX Oncology Short Interest Data Invivyd Short Interest Data Adverum Biotechnologies Short Interest Data Adlai Nortye Short Interest Data InflaRx Short Interest Data Werewolf Therapeutics Short Interest Data DURECT Short Interest Data Precision BioSciences Short Interest Data ImageneBio Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATHA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access